273.45
price up icon0.03%   0.08
 
loading
Precedente Chiudi:
$273.37
Aprire:
$273.37
Volume 24 ore:
594.21K
Relative Volume:
0.67
Capitalizzazione di mercato:
$40.08B
Reddito:
$5.02B
Utile/perdita netta:
$1.31B
Rapporto P/E:
30.69
EPS:
8.91
Flusso di cassa netto:
$1.56B
1 W Prestazione:
+6.65%
1M Prestazione:
+6.86%
6M Prestazione:
+9.16%
1 anno Prestazione:
+32.62%
Intervallo 1D:
Value
$271.01
$274.00
Intervallo di 1 settimana:
Value
$256.53
$274.00
Portata 52W:
Value
$196.43
$274.00

Resmed Inc Stock (RMD) Company Profile

Name
Nome
Resmed Inc
Name
Telefono
(858) 746-2400
Name
Indirizzo
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA
Name
Dipendente
9,980
Name
Cinguettio
@resmed
Name
Prossima data di guadagno
2024-10-24
Name
Ultimi documenti SEC
Name
RMD's Discussions on Twitter

Confronta RMD con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Instruments & Supplies icon
RMD
Resmed Inc
273.35 39.21B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
488.64 183.15B 9.15B 2.61B 1.75B 7.17
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
183.62 51.96B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ALC
Alcon Inc
91.89 43.85B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
278.21 15.73B 2.90B 467.20M 306.90M 6.37

Resmed Inc Stock (RMD) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-15 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2025-03-19 Iniziato Morgan Stanley Overweight
2025-01-16 Iniziato Goldman Buy
2025-01-10 Iniziato Piper Sandler Neutral
2024-12-13 Iniziato Stifel Hold
2024-09-24 Iniziato Robert W. Baird Outperform
2024-09-18 Downgrade Wolfe Research Peer Perform → Underperform
2024-09-04 Downgrade Needham Buy → Hold
2024-06-25 Downgrade Oppenheimer Outperform → Perform
2024-06-24 Downgrade Citigroup Buy → Neutral
2024-02-06 Ripresa KeyBanc Capital Markets Overweight
2023-10-27 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2023-10-12 Downgrade RBC Capital Mkts Outperform → Sector Perform
2023-10-09 Aggiornamento JP Morgan Neutral → Overweight
2023-09-29 Downgrade Wolfe Research Outperform → Peer Perform
2023-09-06 Aggiornamento Needham Hold → Buy
2023-09-05 Downgrade UBS Buy → Neutral
2023-08-01 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2023-05-23 Iniziato UBS Buy
2023-04-14 Iniziato Mizuho Buy
2023-01-17 Aggiornamento JP Morgan Neutral → Overweight
2022-10-28 Downgrade Citigroup Buy → Neutral
2022-10-20 Aggiornamento BofA Securities Neutral → Buy
2022-10-12 Iniziato Jefferies Hold
2022-09-08 Aggiornamento Citigroup Neutral → Buy
2022-08-15 Downgrade CLSA Buy → Outperform
2022-08-12 Downgrade Citigroup Buy → Neutral
2022-08-12 Downgrade JP Morgan Overweight → Neutral
2022-08-12 Downgrade RBC Capital Mkts Outperform → Sector Perform
2022-06-06 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2022-04-06 Iniziato Wolfe Research Outperform
2022-01-31 Aggiornamento Citigroup Neutral → Buy
2022-01-31 Aggiornamento Goldman Neutral → Buy
2022-01-28 Aggiornamento RBC Capital Mkts Underperform → Sector Perform
2022-01-24 Aggiornamento BofA Securities Underperform → Neutral
2022-01-24 Aggiornamento JP Morgan Neutral → Overweight
2022-01-13 Aggiornamento CLSA Outperform → Buy
2022-01-13 Aggiornamento Robert W. Baird Neutral → Outperform
2021-12-21 Aggiornamento KeyBanc Capital Markets Sector Weight → Overweight
2021-12-06 Aggiornamento Macquarie Neutral → Outperform
2021-10-22 Aggiornamento CLSA Underperform → Outperform
2021-08-02 Downgrade CLSA Outperform → Sell
2021-08-02 Downgrade Needham Buy → Hold
2021-07-28 Aggiornamento Jefferies Underperform → Hold
2021-07-26 Downgrade JP Morgan Overweight → Neutral
2021-07-14 Iniziato RBC Capital Mkts Underperform
2021-06-28 Downgrade Citigroup Buy → Neutral
2021-06-22 Aggiornamento Macquarie Neutral → Outperform
2021-06-22 Iniziato Robert W. Baird Neutral
2021-06-21 Reiterato Needham Buy
2021-06-16 Downgrade BofA Securities Neutral → Underperform
2021-06-09 Aggiornamento CLSA Sell → Outperform
2021-05-21 Aggiornamento JP Morgan Neutral → Overweight
2021-05-11 Aggiornamento Citigroup Neutral → Buy
2021-04-30 Downgrade Citigroup Buy → Neutral
2021-03-16 Aggiornamento Needham Hold → Buy
2020-11-02 Aggiornamento UBS Neutral → Buy
2020-10-30 Aggiornamento JP Morgan Underweight → Neutral
2020-10-27 Aggiornamento BofA Securities Underperform → Neutral
2020-08-07 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-06-17 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2020-05-01 Downgrade JP Morgan Neutral → Underweight
2020-05-01 Aggiornamento Oppenheimer Perform → Outperform
2020-02-18 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-02-03 Iniziato CLSA Underperform
2020-01-31 Downgrade UBS Buy → Neutral
2020-01-10 Iniziato Oppenheimer Perform
2019-11-22 Iniziato KeyBanc Capital Markets Sector Weight
2019-07-29 Aggiornamento UBS Neutral → Buy
2019-07-16 Downgrade UBS Buy → Neutral
2019-05-06 Aggiornamento UBS Neutral → Buy
2019-04-18 Aggiornamento JP Morgan Underweight → Neutral
2019-01-25 Downgrade Goldman Buy → Neutral
2019-01-25 Downgrade JP Morgan Neutral → Underweight
2018-10-26 Aggiornamento Credit Suisse Neutral → Outperform
2018-07-02 Iniziato Goldman Buy
Mostra tutto

Resmed Inc Borsa (RMD) Ultime notizie

pulisher
12:10 PM

Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance

12:10 PM
pulisher
12:01 PM

What analysts say about ResMed Inc. stockSuperior portfolio returns - jammulinksnews.com

12:01 PM
pulisher
10:00 AM

ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance

10:00 AM
pulisher
08:30 AM

If You Invested $1000 in ResMed a Decade Ago, This is How Much It'd Be Worth Now - Yahoo Finance

08:30 AM
pulisher
08:04 AM

Here's What To Expect From ResMed's Next Earnings Report - Barchart.com

08:04 AM
pulisher
Jul 23, 2025

MIN and Resmed CDI: 2 ASX shares to dig into - Rask Media

Jul 23, 2025
pulisher
Jul 23, 2025

ResMed Inc. (RMD) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

What drives ResMed Inc. stock priceFree Investment Timing Strategies - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

ResMed Inc. Stock Analysis and ForecastFree Investment Portfolio Suggestions - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Is ResMed Inc. a good long term investmentMarket-beating returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

ResMed stock hits 52-week high at 263.62 USD By Investing.com - Investing.com Nigeria

Jul 22, 2025
pulisher
Jul 21, 2025

Sleep Apnea Devices Market is expected to generate a revenue of USD 14.59 Billion by 2031, Globally, at 10.42 % CAGR: Verified Market Research® - GlobeNewswire Inc.

Jul 21, 2025
pulisher
Jul 19, 2025

Published on: 2025-07-19 18:08:41 - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

What makes ResMed Inc. stock attractive to long term investorsTrend Based Entry Alerts - beatles.ru

Jul 19, 2025
pulisher
Jul 17, 2025

This ResMed Insider Reduced Their Stake By 72% - simplywall.st

Jul 17, 2025
pulisher
Jul 17, 2025

This Pick Withstood the GLP-1 Challenge. Stick With the Stock. - Barron's

Jul 17, 2025
pulisher
Jul 16, 2025

Analyst Expectations For ResMed's Future - Nasdaq

Jul 16, 2025
pulisher
Jul 16, 2025

ResMed (RMD) Price Target Increased to $270 by Mizuho Analyst | - GuruFocus

Jul 16, 2025
pulisher
Jul 16, 2025

Brokers Set Expectations for ResMed's Q1 Earnings (NYSE:RMD) - MarketBeat

Jul 16, 2025
pulisher
Jul 15, 2025

RBC Upgrades ResMed to Outperform From Sector Perform, Adjusts Price Target to $294 From $255 - MarketScreener

Jul 15, 2025
pulisher
Jul 14, 2025

ResMed's Trading Volume Surges 78.7% to 2.35 Billion, Stock Price Drops 0.11% Placing 406th in Market Rankings - AInvest

Jul 14, 2025
pulisher
Jul 14, 2025

ResMed (NYSE:RMD) Seems To Use Debt Rather Sparingly - 富途牛牛

Jul 14, 2025
pulisher
Jul 09, 2025

ResMed CEO Executes Stock Transactions Under Rule 10b5-1 Plan - TipRanks

Jul 09, 2025
pulisher
Jul 09, 2025

Resmed CEO Farrell sells $2.06 million in stock By Investing.com - Investing.com Canada

Jul 09, 2025
pulisher
Jul 09, 2025

Resmed Insider Sold Shares Worth $2,056,076, According to a Recent SEC Filing - MarketScreener

Jul 09, 2025
pulisher
Jul 07, 2025

ResMed Inc. Officer Plans Sale of Common Stock Under Rule 144 - TipRanks

Jul 07, 2025
pulisher
Jul 05, 2025

With 75% institutional ownership, ResMed Inc. (NYSE:RMD) is a favorite amongst the big guns - simplywall.st

Jul 05, 2025
pulisher
Jul 03, 2025

ResMed CFO Reports Changes in Stock Ownership - TipRanks

Jul 03, 2025
pulisher
Jul 03, 2025

ResMed to Release Q4 2025 Financial Results on July 31, 2025, via Webcast - AInvest

Jul 03, 2025
pulisher
Jul 02, 2025

ResMed Executives Sell Shares Under Pre-arranged Trading Plans - TradingView

Jul 02, 2025
pulisher
Jul 02, 2025

ResMed Director Announces Further Share Sale - TipRanks

Jul 02, 2025
pulisher
Jul 01, 2025

ResMed Chief Legal Officer Sells Shares - MarketScreener

Jul 01, 2025
pulisher
Jul 01, 2025

Resmed Inc Officer Files Notice for Stock Sale Under Rule 144 - TipRanks

Jul 01, 2025
pulisher
Jul 01, 2025

Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025 | RMD Stock News - GuruFocus

Jul 01, 2025
pulisher
Jul 01, 2025

Resmed Announces Fourth Quarter Fiscal Year 2025 Financial Results Release and Webcast Details - Quiver Quantitative

Jul 01, 2025
pulisher
Jul 01, 2025

ResMed (NYSE:RMD) Shows Growth in ROCE and Business Efficiency NYSE Composite - Kalkine Media

Jul 01, 2025
pulisher
Jul 01, 2025

ResMed (NYSE:RMD) Could Become A Multi-Bagger - Yahoo Finance

Jul 01, 2025
pulisher
Jun 26, 2025

Zacks.com featured highlights Sprouts Farmers Market, Adobe, GE Aerospace and ResMed - Yahoo Finance

Jun 26, 2025
pulisher
Jun 25, 2025

All You Need to Know About ResMed (RMD) Rating Upgrade to Buy - Nasdaq

Jun 25, 2025
pulisher
Jun 19, 2025

Is the ResMed share price still cheap? What the numbers say - The Motley Fool Australia

Jun 19, 2025
pulisher
Jun 18, 2025

ResMed’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance

Jun 18, 2025
pulisher
Jun 17, 2025

Bi Level Automatic Ventilator Market Is Booming Worldwide 2025-2032 | ResMed Inc., Philips Healthcare, Medtronic Plc - openPR.com

Jun 17, 2025
pulisher
Jun 16, 2025

ResMed Stock: Is RMD Outperforming the Healthcare Sector? - MSN

Jun 16, 2025
pulisher
Jun 16, 2025

ResMed Inc. (RMD) Investor Outlook: Analyzing Growth Potential Amidst a 6% Upside - DirectorsTalk Interviews

Jun 16, 2025
pulisher
Jun 16, 2025

ResMed Stock: Is RMD Outperforming The Healthcare Sector? - Barchart.com

Jun 16, 2025
pulisher
Jun 10, 2025

Resmed CEO Michael Farrell sells shares worth $2.01 million By Investing.com - Investing.com South Africa

Jun 10, 2025
pulisher
Jun 10, 2025

ResMed: A Mixed Bag for Investors Amid Rising Competition - The Globe and Mail

Jun 10, 2025

Resmed Inc Azioni (RMD) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
medical_instruments_supplies ALC
$91.89
price down icon 0.30%
medical_instruments_supplies BDX
$183.68
price up icon 0.53%
medical_instruments_supplies WST
$277.75
price up icon 22.38%
medical_instruments_supplies BAX
$28.79
price up icon 0.63%
medical_instruments_supplies COO
$73.59
price up icon 0.30%
Capitalizzazione:     |  Volume (24 ore):